Chemotherapy in Japanese advanced lung cancer patients: a descriptive study using database

Chemotherapy in Japanese advanced lung cancer patients: a descriptive study using database - Chemotherapy in advanced lung cancer patients: a descriptive study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016418

Enrollment

1000

Registered

2015-02-02

Start date

2015-02-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Diagnosed with C34 in International Classification of Diseases, 10th revision (ICD-10) between 2004/1-2014/9 -Stage IIIB or IV

Exclusion criteria

Exclusion criteria: -18> -Received thoracic radiotherapy within 8 days of 1st chemotherapy -If they had any previously diagnosed cancers -Did not survive at least 30 days past diagnosis

Design outcomes

Primary

Measure	Time frame
The proportion of each chemotherapy regimen.	—

Secondary

Measure	Time frame
Overall survival, costs, adverse events of each chemotherapy regimen.	—

Countries

Japan

Contacts

Public ContactKATAOKA Yuki

Graduate School of Medicine and Public Health, Kyoto University Department of Healthcare Epidemiology

youkitikk@gmail.com075-753-4645

Outcome results